Clinical Trials on Carcinoma, Bronchogenic
Total 23247 results
-
Merck Sharp & Dohme LLCCompleted
-
R-PharmCompletedCarcinoma, Non-small-cell LungUnited States
-
Spanish Lung Cancer GroupTerminatedCarcinoma, Non Small Cell LungSpain
-
University of Alabama at BirminghamAscenta TherapeuticsWithdrawnCarcinoma, Non Small Cell Lung
-
PfizerCompletedLung Neoplasms | Carcinoma, Non-small Cell LungUnited States, Germany
-
TelikCompletedCarcinoma, Non-small-cell LungUnited States
-
Eli Lilly and CompanyCompletedCarcinoma, Non Small Cell LungUnited States
-
PfizerCompletedCarcinoma, Non-Small Cell LungUnited States, Canada
-
Johnson & Johnson Enterprise Innovation Inc.RecruitingCarcinoma, Non-small-Cell LungKorea, Republic of, Spain, United States, Germany
-
Mayo ClinicRecruitingLung Non-Small Cell CarcinomaUnited States
-
Sun Yat-sen UniversityRecruitingCarcinoma，Non-Small-Cell LungChina
-
Roswell Park Cancer InstituteActive, not recruitingLung Non-Small Cell CarcinomaUnited States
-
PfizerCompletedNon-Small Cell Lung CarcinomaTaiwan
-
University of Texas Southwestern Medical CenterTexas Tech University Health Sciences Center; BerGenBio ASACompletedNon-Small Cell Lung CarcinomaUnited States
-
Hoffmann-La RocheCompletedCarcinoma, Non-small-cell LungArgentina
-
The Netherlands Cancer InstituteDutch Society of Physicians for Pulmonology and TuberculosisActive, not recruitingCarcinoma, Non-Small Cell LungNetherlands
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCCompletedCarcinoma, Non-small Cell LungUnited States, Spain
-
University of Wisconsin, MadisonMedical College of Wisconsin; Ohio State University; Optimum Therapeutics, LLCCompletedCarcinoma, Non Small Cell LungUnited States
-
Eli Lilly and CompanyCompletedCarcinoma, Non Small Cell LungTaiwan, Japan, Korea, Republic of, China
-
Shandong Cancer Hospital and InstituteUnknownCarcinoma, Non-Small Cell LungChina
-
Weill Medical College of Cornell UniversityOSI PharmaceuticalsCompletedCarcinoma, Non-small Cell LungUnited States
-
Yale UniversityTerminatedCarcinoma, Non-small Cell LungUnited States
-
Chonnam National University HospitalSanofiTerminatedCarcinoma, Non Small Cell LungKorea, Republic of
-
Wolfgang HilbeSanofi; Merck Sharp & Dohme LLC; TAKO - Tiroler Arbeitskreis OnkologieCompletedCarcinoma, Non-small-cell LungAustria
-
TelikCompletedCarcinoma, Non-small-cell LungUnited States
-
Point TherapeuticsTerminatedCarcinoma, Non-Small Cell LungUnited States
-
Eli Lilly and CompanyCompletedCarcinoma, Non-Small Cell LungChina, Taiwan, Australia, Korea, Republic of, Egypt, Romania, India, Turkey
-
Eli Lilly and CompanyCompletedCarcinoma, Non Small Cell LungUnited States
-
The Netherlands Cancer InstituteAstraZenecaRecruitingOsimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. (OSIRIS)Non-small-cell Lung CarcinomaNetherlands
-
University Health Network, TorontoActive, not recruitingNon-small Cell Lung CarcinomaCanada
-
European Lung Cancer Working PartyActive, not recruiting
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungSpain, Korea, Republic of, Turkey, France, United States
-
European Lung Cancer Working PartyTerminatedNon-small Cell Lung CarcinomaBelgium, France, Spain, Greece
-
Roswell Park Cancer InstituteRecruitingExtensive Stage Lung Small Cell CarcinomaUnited States
-
Boehringer IngelheimRecruitingSmall Cell Lung Carcinoma (SCLC)Spain, Belgium, Japan, France, Poland, Germany
-
Fox Chase Cancer CenterNational Comprehensive Cancer NetworkRecruitingNon-Small Cell Carcinoma of Lung, TNM Stage 4United States
-
Guangdong Association of Clinical TrialsRecruitingNon-Small Cell Carcinoma of Lung, TNM Stage 4China
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingAdvanced Squamous Non-Small Cell Lung CarcinomaChina
-
University of Illinois at ChicagoRecruitingMetastatic Squamous Non-Small Cell Lung CarcinomaUnited States
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCPoland, Taiwan, Thailand, Vietnam, United States, Korea, Republic of, Hungary, Russian Federation, Turkey, China, Australia, Netherlands
-
AstraZenecaActive, not recruitingNon-Small-Cell Lung Carcinoma NSCLCUnited States, Belgium, Spain, Canada, Taiwan, Thailand, Vietnam, France, Germany, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, Netherlands, Australia, Switzerland
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCDenmark, United Kingdom, United States, Poland, Brazil, India, Japan, Mexico, Peru, Russian Federation, Turkey, China, Malaysia, Hong Kong, Korea, Republic of, Chile, Israel, Ukraine, Portugal, Greece, Bulgaria, Philippines, Sweden, A... and more
-
Merck Sharp & Dohme LLCCompleted
-
Center Trials & Treatment EuropeCenter Trials & TreatmentActive, not recruitingNon Small Cell Lung CancerGeorgia
-
Peter MacCallum Cancer Centre, AustraliaCompletedNon-small Cell Lung CancerAustralia, Canada
-
National Cancer Institute (NCI)CompletedNon-Small-Cell Lung CarcinomaUnited States, Mexico, Bolivia, Peru, Venezuela
-
National Cancer Institute (NCI)University of Chicago; City of Hope Medical Center; University of Southern California and other collaboratorsCompleted
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States
-
University Hospital, BordeauxCompletedLung Cancer | Non-small-cell Lung CarcinomaFrance
-
Genentech, Inc.CompletedLung Cancer | Non-small-cell Lung CarcinomaUnited States